A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Baricitinib Impurity 21 - Request Quote

Picture of Baricitinib Impurity 21

Baricitinib Impurity 21

SZ CAT No:SZ-B038032
CAS No
NA
Mol.F.
C20H26N8O4S2
Mol.Wt.
506.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Baricitinib Impurity 21 is chemically 2,2'-(1H,1'H-[4,4'-Bipyrazole]-1,1'-diylbis(1-(ethylsulfonyl)azetidine-3,3-diyl))diacetonitrile. Baricitinib Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Baricitinib Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Baricitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Baricitinib Impurity 21

Purchase Baricitinib Impurity 21

Baricitinib Impurity 21 suppliers

Baricitinib Impurity 21 manufacturers

Baricitinib Impurity 21 price

Order Baricitinib Impurity 21

Enquire Baricitinib Impurity 21

Baricitinib Impurity 21 cost

Baricitinib Impurity 21 Supplier

Baricitinib Impurity 21 Distributor

Baricitinib Impurity 21 for Method Validation

Baricitinib Reference Standard

Baricitinib Impurity 21 for ANDA Filing

Baricitinib Impurity 21 for Forced Degradation Studies

Baricitinib Impurity 21 Identification Standards

Baricitinib Impurity 21 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,